Geron Corporation’s Post

From novel therapeutic advancements to significant updates in cancer care protocols, here are some of the major updates in oncology from #ESMO24. https://lnkd.in/em_j6TfE

📢 It's finally Day 1 of #ASCO24! Today's feature is the RadicaL Study for patients with metastatic kidney cancer. Swipe to learn more! American Society of Clinical Oncology (ASCO) PI: Rana McKay UC San Diego Bayer Alliance for Clinical Trials in Oncology

🗓️ Add this to your calendars! You won’t want to miss NCI’s session on Survivorship in Advanced Lung Cancer on June 3 at the American Society of Clinical Oncology (ASCO)'s annual meeting! In this session, you'll hear about how to address the needs of patients who are commonly excluded from clinical trials due to factors such as age and health issues. http://spr.ly/6040eIfgA #ASCO24 #CancerResearch #LCSM

About one-third of patients newly diagnosed with cancer reported having a major adverse financial event (AFE) before diagnosis, and those with previous AFEs are more likely to be diagnosed with later-stage cancer, according to a study published online Feb. 6 in the Journal of Clinical Oncology. https://buff.ly/3Ve5nOS #AdverseFinancialEvent #CancerPatients #SeriousIllness

This partnership is one more step to improving patient outcomes & solidifying the stat of 30% increase in treatment adherence when practices utilize our programs. Let's bump up that number by engaging patients during office & treatment visits with communications centered around improving THEIR outcomes. Let's work together to give patients the knowledge to make the best decision for them. #oncologycare #patientadvocacy #patientempowerment

The future of oncology with 'Radiotheranostics: Making Precision Medicine Possible.' Learn how targeted radiopharmaceuticals revolutionize cancer treatment. A must-read for healthcare pioneers! #pubrica #Radiotheranostics #OncologyInnovation  Learn More: https://lnkd.in/gUzXr74y

Are you interested in hearing about strategies on how to enhancing efficiency in early phase oncology trials? Click below to register for the event where our experts Bin Pan and Mike Mendoza will be sharing their thoughts and experiences on this topic. #TFSHealthScience #TFSCRO #EarlyPhaseOncologyTrials #ClinicalTrials #AcceleratingDataFlow #Oncology

Curious about integrative oncology? Discover how it differs from alternative medicine and its potential benefits for cancer survivors. Expand your knowledge: https://lnkd.in/e-xRj8nG #IntegrativeOncology #CancerSurvivorship

Four key solutions to address barriers for decentralizing trials to improve patient access Archana Sah MS (Pharm.), PMP American Society of Clinical Oncology (ASCO) Phuong Ly-Gallagher https://lnkd.in/gED27MRN #ASCO #cancer #CancerCare #OncoDaily #Oncology

Just published in the Journal of Clinical Oncology, results from a monarchE overall survival interim analysis, including 5-year efficacy outcomes in HR+, HER2-, node-positive early breast cancer patients at high risk of disease recurrence. Click here to see the publication in JCO: https://e.lilly/4aNZluf #EarlyBreastCancer #BreastCancer #bcsm